A study protocol for an observational cohort investigating cardiac transthyretin amyloidosis flow reserve before and after Tafamidis treatment: The AMYTRE study

A study protocol for an observational cohort investigating cardiac transthyretin amyloidosis flow reserve before and after Tafamidis treatment: The AMYTRE study

IntroductionAnginal symptoms and signs of ischemia have been reported in some patients with cardiac transthyretin amyloidosis (ATTR) without obstructive epicardial coronary artery disease (CAD). Few studies found that coronary microvascular dysfunction was highly prevalent in subjects with cardiac a...

Full description

Bibliographic Details
Main Authors: Bastien Vançon, Arnaud Bisson, Maxime Courtehoux, Anne Bernard, Matthieu Bailly
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Medicine
Subjects:
myocardial blood flow
myocardial flow reserve
CZT SPECT
amyloidosis
Tafamidis
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2022.978293/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2022.978293/full

Similar Items